卢非酰胺薄膜片——单一且有效的抗癫痫药物

Ms. Wang's son is five years old and is in the first grade of elementary school. Recently, teachers have reported to Ms. Wang that the child is dazed during class, his eyes are staring straight, and he will suddenly stop the movement of his hands. At first, Ms. Wang thought that the child just had ADHD, but then he developed symptoms of rapid limb twitching. After examination at the hospital, he was diagnosed with Lennox-Gastaut syndrome, a rare epilepsy that can only be treated with orphan drugs.

Lennox-Gastaut syndrome faces dilemma

Lennox-Gastaut syndrome is an age-related generalized epilepsy syndrome with a peak age of onset between 3 and 5 years old. Seizures occur in various forms and affect children's intelligence. At present, most anti-epileptic drugs have no obvious effect on this disease, and because of the frequent seizures, patients quickly develop resistance to a small number of effective drugs. This disease tends to use multiple drugs in combination, which can easily produce toxic side effects. Patients urgently need a single and effective anti-epileptic drug treatment.

The emergence of rufinamide film tablets breaks the dilemma of no drug available

Rufinamide film tablet is an anti-epileptic drug. It works through special channels attached to the surface of brain cells (sodium channels), which control the cell's electrical activity. By connecting to the channels, the rufinamide film sheet prevents them from switching from an inactive to an active state. This inhibits the activity of brain cells and prevents abnormal electrical activity from spreading through the brain. This greatly reduces the likelihood of seizures.

How effective are rufinamide film tablets? Experimental data speaks for itself!

The clinical research institution conducted a study on 139 patients aged between 4 and 30 years old (most patients were under 17 years old). All patients had Lennox-Gastaut syndrome. During the treatment, they used a variety of epilepsy drugs and placebos. After four weeks of treatment, there was no significant improvement in symptoms. The researchers added rufinamide film tablets to the treatment for four weeks. Compared with data from the first four weeks, patients who added rufinamide film tablets had a 42.5% reduction in seizures.

Possible side effects of taking Rufinamide film tablets

The most common side effects (more than 1 in 10 patients) of nonamide film tablets are drowsiness (drowsiness), headache, dizziness, nausea (feeling unwell), vomiting, and fatigue (tiredness). Non-amide film tablets should not be used in patients who are allergic (allergic) to remifenamide, triazole derivatives (such as certain drugs used to treat fungal infections), or any other ingredient.

How to buy Rufinamide film tablets?

The European Commission granted rufinamide film tablets marketing authorization across the EU on January 16, 2007. However, the drug has not yet been marketed in China, so it cannot be purchased domestically. Patients can entrust their medical companions to travel abroad to purchase medicines, and have them delivered directly to their homes. The specific price fluctuates with the exchange rate. If you have any questions about medicines or purchasing issues, please contact the Medical Companion Travel Service.